Barclays raised the firm’s price target on Helmerich & Payne to $39 from $36 and keeps an Overweight rating on the shares. The firm views the company’s Q4 report as solid.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HP:
- Helmerich & Payne price target raised to $38 from $35 at TD Cowen
- Helmerich & Payne price target raised to $40 from $35 at Piper Sandler
- Hold Rating Maintained as Near-Term Margin Headwinds Offset Longer-Term Normalization at HP
- Helmerich & Payne Earnings Call Highlights Cash, Debt Wins
- Helmerich & Payne Maintains Stable Risk Profile With No Material Changes in 2025 10-K Disclosures